Vericel Announces Preliminary Fourth-Quarter and Full-Year 2020 Financial Results and Provides Business UpdatesGlobeNewsWire • 01/11/21
Vericel to Present at the 23rd Annual Needham Growth Conference on Friday, January 15, 2021GlobeNewsWire • 01/08/21
Vericel Announces Expansion of MACI Coverage by UnitedHealthcare to Include Patella and Multiple Cartilage Defects in the KneeGlobeNewsWire • 01/07/21
Vericel: Biotech Leader In Engineered Tissue Solutions With Rapid Growth & ProfitabilitySeeking Alpha • 01/04/21
Vericel to Present at the 39th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2021GlobeNewsWire • 12/18/20
Vericel Corporation (VCEL) CEO Nick Colangelo on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/06/20
Vericel Announces Preliminary Third Quarter 2020 Total Net Revenues of $32 MillionGlobeNewsWire • 10/14/20
Vericel Announces FDA Acceptance of Biologics License Application for NexoBrid for the Treatment of Severe Thermal BurnsGlobeNewsWire • 09/16/20
Vericel to Present at the 18th Annual Morgan Stanley Global Healthcare Conference on Thursday, September 17, 2020GlobeNewsWire • 09/04/20
MediWound and Vericel Announce Acceptance of the First Delivery of NexoBrid to BARDA for Emergency Response PreparednessGlobeNewsWire • 08/25/20
Vericel Corporation (VCEL) CEO Nick Colangelo on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/05/20
Do Options Traders Know Something About Vericel (VCEL) Stock We Don't?Zacks Investment Research • 07/15/20